Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10269), 99-111, 2021 | 5384 | 2021 |
First report of autochthonous transmission of Zika virus in Brazil C Zanluca, VCA Melo, ALP Mosimann, GIV Santos, CND Santos, K Luz Memórias do Instituto Oswaldo Cruz 110, 569-572, 2015 | 1726 | 2015 |
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four … M Voysey, SAC Clemens, SA Madhi, LY Weckx, PM Folegatti, PK Aley, ... The Lancet 397 (10277), 881-891, 2021 | 1356 | 2021 |
Efficacy of a tetravalent dengue vaccine in children in Latin America L Villar, GH Dayan, JL Arredondo-García, DM Rivera, R Cunha, ... New England Journal of Medicine 372 (2), 113-123, 2015 | 1118 | 2015 |
Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 … VC Marconi, AV Ramanan, S de Bono, CE Kartman, V Krishnan, R Liao, ... The lancet Respiratory medicine 9 (12), 1407-1418, 2021 | 682 | 2021 |
Pathology of congenital Zika syndrome in Brazil: a case series RB Martines, J Bhatnagar, AM de Oliveira Ramos, HPF Davi, ... The Lancet 388 (10047), 898-904, 2016 | 401 | 2016 |
Efficacy of a tetravalent dengue vaccine in healthy children and adolescents S Biswal, H Reynales, X Saez-Llorens, P Lopez, C Borja-Tabora, ... New England Journal of Medicine 381 (21), 2009-2019, 2019 | 312 | 2019 |
Zika virus damages the human placental barrier and presents marked fetal neurotropism L Noronha, C Zanluca, MLV Azevedo, KG Luz, CND Santos Memórias do Instituto Oswaldo Cruz 111, 287-293, 2016 | 311 | 2016 |
Effect of sotrovimab on hospitalization or death among high-risk patients with mild to moderate COVID-19: a randomized clinical trial A Gupta, Y Gonzalez-Rojas, E Juarez, MC Casal, J Moya, DR Falci, ... Jama 327 (13), 1236-1246, 2022 | 249 | 2022 |
Long lasting protection against canine kala-azar using the FML-QuilA saponin vaccine in an endemic area of Brazil (Sao Goncalo do Amarante, RN) GP Borja-Cabrera, NNC Pontes, VO Da Silva, EP De Souza, WR Santos, ... Vaccine 20 (27-28), 3277-3284, 2002 | 228 | 2002 |
Efficacy of a tetravalent dengue vaccine in healthy children aged 4–16 years: a randomised, placebo-controlled, phase 3 trial S Biswal, C Borja-Tabora, LM Vargas, H Velásquez, MT Alera, V Sierra, ... The Lancet 395 (10234), 1423-1433, 2020 | 224 | 2020 |
An urban outbreak of visceral leishmaniasis in Natal, Brazil SMB Jeronimo, RM Oliveira, S Mackay, RM Costa, J Sweet, ... Transactions of the Royal Society of Tropical Medicine and Hygiene 88 (4 …, 1994 | 222 | 1994 |
A phase III trial of efficacy of the FML-vaccine against canine kala-azar in an endemic area of Brazil (Sao Goncalo do Amaranto, RN) VO da Silva, GP Borja-Cabrera, NNC Pontes, EP de Souza, KG Luz, ... Vaccine 19 (9-10), 1082-1092, 2000 | 196 | 2000 |
Efficacy and safety of baricitinib plus standard of care for the treatment of critically ill hospitalised adults with COVID-19 on invasive mechanical ventilation or … EW Ely, AV Ramanan, CE Kartman, S de Bono, R Liao, MLB Piruzeli, ... The Lancet Respiratory Medicine 10 (4), 327-336, 2022 | 165 | 2022 |
Three-year efficacy and safety of Takeda’s dengue vaccine candidate (TAK-003) L Rivera, S Biswal, X Sáez-Llorens, H Reynales, E López-Medina, ... Clinical Infectious Diseases 75 (1), 107-117, 2022 | 140 | 2022 |
Febre pelo vírus Zika KG Luz, GIV Santos, RM Vieira Epidemiologia e Serviços de Saúde 24, 785-788, 2015 | 125 | 2015 |
occurrence of Leishmania donovani DNA in donated blood from seroreactive Brazilian blood donors. AC Otero, VO da Silva, KG Luz, M Palatnik, C Pirmez, O Fernandes, ... The American journal of tropical medicine and hygiene 62 (1), 128-131, 2000 | 95 | 2000 |
Treatment of Brazilian kala-azar with a short course of amphocil (amphotericin B cholesterol dispersion) R Dietze, EP Milan, JD Berman, M Grogl, A Falqueto, TF Feitosa, KG Luz, ... Clinical infectious diseases 17 (6), 981-986, 1993 | 95 | 1993 |
Prevalence of anti-Leishmania donovani antibody among Brazilian blood donors and multiply transfused hemodialysis patients. KG Luz, VO Da Silva, EM Gomes, FC Machado, MA Araujo, HE Fonseca, ... The American journal of tropical medicine and hygiene 57 (2), 168-171, 1997 | 91 | 1997 |
Efficacy of the adjuvanted subunit protein COVID-19 vaccine, SCB-2019: a phase 2 and 3 multicentre, double-blind, randomised, placebo-controlled trial L Bravo, I Smolenov, HH Han, P Li, R Hosain, F Rockhold, SAC Clemens, ... The Lancet 399 (10323), 461-472, 2022 | 89 | 2022 |